Del 75 i serien Progress in Drug Research

Carbonic Anhydrases: Current and Emerging Therapeutic Targets

Häftad, Engelska, 2022

AvW. Richard Chegwidden,Nicholas D. Carter

1 429 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

The existing and potential therapeutic applications of targeting CA cover a remarkably wide-range of diseases and disorders and have generated increasing and extensive interest in recent years.

Produktinformation

Utgivningsdatum2022-10-31
Mått155 x 235 x 17 mm
Vikt458 g
FormatHäftad
SpråkEngelska
SerieProgress in Drug Research
Antal sidor288
FörlagSpringer Nature Switzerland AG
ISBN9783030795139

Tillhör följande kategorier

Dedication.- Preface.-The carbonic anhydrases in health and disease.- Carbonic anhydrase isozymes as diagnostic biomarkers and therapeutic targets.- Targeting carbonic anhydrases in vascular and pulmonary disease.- Carbonic anhydrase inhibitors in ophthalmology: glaucoma and macular oedema.- Targeting carbonic anhydrase isozymes in the treatment of neurological disorders.- Potential of carbonic anhydrase inhibitors in the treatment of oxidative stress and diabetes.- An overview of carbonic anhydrase-related neoplasms.- The carbonic anhydrase IX interactome and the regulation of cancer progression.- Carbonic anhydrase IX: current and emerging therapies.- Carbonic anhydrase inhibitors: designing isozyme-specific inhibitors as therapeutic agents.- Carbonic anhydrase inhibitors: identifying therapeutic cancer agents through virtual screening.- Targeting carbonic anhydrase IX in tumour imaging and theranostic cancer therapy.